Tag : CoTransporter

Cardiology

Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.

Newsemia
Related Articles Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2020 Oct...
Cardiology

Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure.

Newsemia
Related Articles Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure. Heart Fail Rev. 2020 Nov 04;: Authors: Dutka M, Bobiński R, Ulman-Włodarz...
Cardiology

Cardio-protective effects of sodium-glucose co-transporter 2 inhibitors: focus on heart failure.

Newsemia
Related Articles Cardio-protective effects of sodium-glucose co-transporter 2 inhibitors: focus on heart failure. Curr Pharm Des. 2020 Nov 03;: Authors: Karangelis D, Mazer CD, Stakos...
Cardiology

TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity.

Newsemia
Related Articles TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity. Biology (Basel). 2020...
Cardiology

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus.

Newsemia
Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2020 Oct...
Cardiology

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.

Newsemia
Related Articles Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study. BMJ. 2020 09 23;370:m3342 Authors: Filion KB,...
Cardiology

Sodium-glucose Cotransporter 2 Inhibitors- a Drug with Anti-diabetic and Cardioprotective Properties.

Newsemia
Related Articles Sodium-glucose Cotransporter 2 Inhibitors- a Drug with Anti-diabetic and Cardioprotective Properties. J Diabetes Investig. 2020 Sep 23;: Authors: Li HY Abstract Recently, two...
Cardiology

Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors.

Newsemia
Related Articles Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors. Circ...
Cardiology

Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care.

Newsemia
Related Articles Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care. Cardiovasc Diabetol. 2020 Sep 02;19(1):132 Authors: Tanaka A,...
Cardiology

Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus.

Newsemia
Related Articles Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020 Aug 27;: Authors: Scheen AJ Abstract...
Pharma / Biotech

Effects of Child-Pugh B Cirrhosis on Pharmacokinetics of Tofogliflozin, a New Sodium-Glucose Co-Transporter (SGLT2) Inhibitor.

Newsemia
Related Articles Effects of Child-Pugh B Cirrhosis on Pharmacokinetics of Tofogliflozin, a New Sodium-Glucose Co-Transporter (SGLT2) Inhibitor. Drug Res (Stuttg). 2020 Jul 24;: Authors: Yamada...
Cardiology

Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients.

Newsemia
Related Articles Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients. J Diabetes Investig. 2020...
Pharma / Biotech

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease.

Newsemia
Related Articles Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease. Eur J Clin Pharmacol. 2019 Aug...
Biology

Comprehensive analysis of genes contributing to euryhalinity in the bull shark, Carcharhinus leucas; Na+-Cl- co-transporter is one of the key renal factors upregulated in acclimation to low-salinity environment [RESEARCH ARTICLE]

Newsemia
Itaru Imaseki, Midori Wakabayashi, Yuichiro Hara, Taro Watanabe, Souichirou Takabe, Keigo Kakumura, Yuki Honda, Keiichi Ueda, Kiyomi Murakumo, Rui Matsumoto, Yosuke Matsumoto, Masaru Nakamura, Wataru...
Biology

Comprehensive analysis of genes contributing to euryhalinity in the bull shark, Carcharhinus leucas; Na+-Cl- co-transporter is one of the key renal factors up-regulated in acclimation to low-salinity environment in bull sharks, but not in houndsharks, Triakis scyllium [RESEARCH ARTICLE]

Newsemia
Itaru Imaseki, Midori Wakabayashi, Yuichiro Hara, Taro Watanabe, Souichirou Takabe, Keigo Kakumura, Yuki Honda, Keiichi Ueda, Kiyomi Murakumo, Rui Matsumoto, Yosuke Matsumoto, Masaru Nakamura, Wataru...
Biology

With illumination, the fluted giant clam, Tridacna squamosa, upregulates the protein abundance of an apical Na+: glucose cotransporter 1 homolog in its ctenidium, and increases exogenous glucose absorption that can be impeded by urea [RESEARCH ARTICLE]

Newsemia
Christabel Y. L. Chan, Kum C. Hiong, Celine Y. L. Choo, Mel V. Boo, Wai P. Wong, Shit F. Chew, and Yuen K. Ip Giant...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy